D-23129: A new anticonvulsant with a broad spectrum activity in animal models of epileptic seizures

Epilepsy Research

Volumn 23, Issue 3, 1996, Pages 211-223

  Rostock, Angelika ^a   Tober, Christine ^a   Rundfeldt, Chris ^a   Bartsch, Reni ^a   Engel, Jürgen ^a   Polymeropoulos, Emanuele E ^a   Kutscher, Bernhard ^a   Löscher, Wolfgang ^b   Hönack, Dagmar ^b   White, H Steve ^c   Wolf, Harold H ^c  

^a ASTA MEDICA AG   (Germany)

^b UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

^c UNIVERSITY OF UTAH   (United States)

Author keywords

carbamazepine; complex partial seizure; electroshock; p entylenetetrazole; phenobarbital; phenytoin; seizure threshold; valproate

Indexed keywords

ANTICONVULSIVE AGENT; BICUCULLINE; CARBAMAZEPINE; CLONAZEPAM; DIAZEPAM; ETHOSUXIMIDE; N METHYL DEXTRO ASPARTIC ACID; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; PICROTOXIN; RETIGABINE; STRYCHNINE; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SEIZURE;

EID: 0029969951     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-1211(95)00101-8     Document Type: Article

References (34)

1. Dailey, J.W., Cheong, J.H., Ko, K.H., Adams-Curtis, L.E. and Jobe, P.C., Anticonvulsant properties of D-20443 in genetically epilepsy-prone rats: prediction of clinical response, Neurosci. Lett., 195 (1995) 77-80.
2. Dam, M., Intractable epilepsy: Introduction. In: D. Schmidt and P.L. Morselli (Eds.), Intractable Epilepsy: Experimental and Clinical Aspects, Raven Press, New York, NY, 1986, pp. 1-3.
3. Dieter, H.-R., Engel, J., Kutscher, B., Polymeropoulos, E.E., Szelenyi, S. and Nickel, B., Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes of their preparation and pharmaceutical compositions containing them. United States Patent No. US0005,384,330, 1995.
4. Jakovlev, V., Achterrath-Tuckermann, U., von Schlichtegroll, A., Strohman, F. and Thiemer, K., Allgemeine pharmakologische Untersuchungen mit dem Analgetikum Flupirtin (general pharmacological studies with the analgesic flupirtine), Arzneim.-Forsch. / Drug Res., 35 (1985) 44-55.
5. Kapetanovic, I.M., Yonekawa, W.D. and Kupferberg, H.J., The effects of anticonvulsant compounds on 4-aminopyridine-induced de novo synthesis of neurotransmitter amino acids in rat hippocampus in vitro, Epilepsy Res., 20 (1995) 113-120.
6. Kimball, A.W., Burnett, W.T. and Doherty, D.G., Chemical protection against ionizing radiation. I. Sampling methods for screening compounds in radiation protection studies with mice, Radiat. Res., 1 (1957) 1-12.
7. Litchfield, J.T. and Wilcoxon, F., A simplified method of evaluating dose-effect experiments, J. Pharmacol. Exp. Ther., 96 (1949) 99-113.
8. Loiseau, P., Do we need novel anti-epileptic drugs? Br. J. Clin. Pract., 42 (1988) 2-3.
9. Löscher, W., von Hodenberg, A., Nolting, B., Fassbender, C.-P. and Taylor, C., Ralitoline: a reevaluation of anticonvulsant profile and determination of 'active' plasma concentrations in comparison with prototype antiepileptic drugs in mice, Epilepsia, 32 (1991) 560-568.
10. Löscher, W. and Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. IV. Protective indices, Epilepsy Res., 9 (1991) 1-10.
11. Löscher, W., Fassbender, C.P. and Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models, Epilepsy Res., 8 (1991) 79-94.
12. Löscher, W., Hönack, D., Fassbender, C.P. and Nolting, B., The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazol seizure models, Epilepsy Res., 8 (1991) 171-189.
13. Nickel, B., Shandra, A., Godlevsky, L., Mazarati, A., Kupferberg, H. and Szelenyi, I., Antiepileptic effects of a new drug: D-20443, Epilepsia, 34 (Suppl. 2) (1993) 95.
14. Nickel, B., Shandra, A., Godlevsky, L., Mazarati, A., Kupferberg, H. and Szelenyi, I., Anticonvulsant activity of D-20443, Naunyn-Schmiedenberg's Arch. Pharmacol., 347 (Suppl.) (1993) R142.
15. Polymeropoulos, E.E. and Kutscher, B., GABAergic activity of triamino-pyridines and triamino-benzenes. In: C.G. Wermuth (Ed.), Trends in QSAR and Molecular Modelling 92, ESCOM, Leiden, 1993, pp. 456-460.
16. Rundfeldt, C., Rohlfs, A. and Netzer, R., Multiple actions of the new anticonvulsant D-23129 on voltage gated inward currents and GABA-induced currents in cultured neuronal cells, Naunyn Schmiedenberg's Arch. Pharmacol., 351 (Suppl.) (1995) R160.
17. Rundfeldt, C., Tober, C., Rostock, A. and Bartsch, R., The phenylcarbamic acid ester D-23129 elevates potently the threshold for amygdala kindled seizures in rats at nontoxic doses, Epilepsie-Blätter, 7 (1994) 29.
18. Rundfeldt, C., Wlaz, P., Hönack, D. and Löscher, W., Anticonvulsant tolerance and withdrawal characteristics of benzodiazepine receptor ligands in different seizure models in mice. Comparison of diazepam, bretazenil and abecarnil, J. Pharmacol. Exp. Ther. (in press).
19. Sander, J.W.A.S. and Shorvon, S.D., Incidence and preva lence studies in epilepsy and their methodological problems: a review, J. Neurol. Neurosurg. Psychiat., 50 (1987) 829-839.
20. Schmidt, D., Anticonvulsants. In: M.N.G. Duke (Ed.), Meyler's Side Effects of Drugs, 12th edition, Elsevier, Amsterdam, 1992, pp. 122-143.
21. Schmidt, D. and Morselli, P.L. (Eds.), Intractable Epilepsy: Experimental and Clinical Aspects, Raven Press, New York, NY, 1986.
22. Seaman, C.A., Sheridan, P.H., Engel J., Molliere, M., Narang, P.K. and Nice, F.J., Flupirtine. In: B.S. Meldrum and R.J. Porter (Eds), New Amiconvulsant Drugs, Libbey, London, 1986, pp. 135-146.
23. Seydel, J.K., Schaper, K.-J., Coates, E.A., Cordes, H.P., Emig, P., Engel, J., Kutscher, B. and Polymeropoulos, E.E., Synthesis and quantitative structure-activity relationship of anticonvulsant 2,3,6-triaminopyridines, J. Med. Chem., 37 (1994) 3016-3022.
24. Singh, N.A., Swinyard, E.E. and White, H.S., Effects of prototype anticonvulsants on N-methyl-D-aspartate (NMDA)-induced seizures in mice, Fed. Am. Soc. Exp. Biol. J., 2 (1988) A1068.
25. Swinyard, E.A., Laboratory evaluation of antiepileptic drugs. Review of laboratory methods, Epilepsia, 10 (1969) 107-119.
26. Swinyard, E.A., Brown, W.C. and Goodman, L.S., Comparative assay of antiepileptic drugs in mice and rats, J. Pharmacol. Exp. Ther., 106 (1952) 319-330.
27. Swinyard, E.A., Wolf, H.H., White, H.S., Skeen, G.A., Stark, L.G., Albertson, T., Pong, S.F. and Drust, E.G., Characterization of the anticonvulsant properties of F-721, Epilepsy Res., 15 (1993) 35-45.
28. Tober, C., Jainta, H., Rundfeldt, C., Rostock, A. and Bartsch, R., Anticonvulsant and antiepileptogenic effects of D-23129 in the kindling model of focal epilepsy, Naunyn-Schmiedeberg's Arch. Pharmacol, 351 (Suppl.) (1995) R160.
29. Tober, C., Rostock, A., Rundfeldt, C and Bartsch, R., D-23129: a potent anticonvulsant in the amygdala kindling model of complex partial seizures, Eur. J. Pharmacol. (in press).
30. Tober, C., Rundfeldt, C., Rostock, A. and Bartsch, R., The phenylcarbamic acid ester D-23129 is highly effective in epilepsy models for generalised and focal seizures at nontoxic doses, Soc. Neurosci. Abstr., 20 (1994) 1641.
31. Tober, C., Rostock, A. and Bartsch, R., The phenylcarbamic acid ester D-23129 is highly effective against amygdala kindled seizures in rats, Eur. J. Neurosci., (Suppl. 7) (1994) 212.
32. White, H.S., Patel, S. and Meldrum, B.S., Anticonvulsaqnt profile of MDL 27,266: an orally active, broad spectrum anticonvulsant agent, Epilepsy Res., 12 (1992) 217-226.
33. White, H.S., Wolf, H.H., Swinyard, A., Skeen, G.A. and Sofia, R.D., A neuropharmacological evaluation of felbamate as a novel anticonvulsant, Epilepsia, 33 (1992) 564-572.
34. Yonekawa, W.D., Kapetanovic, I.M. and Kupferberg, H.J., The effects of anticonvulsant agents on 4-aminopyridine induced epileptiform activity in rat hippocampus in vitro, Epilepsy Res., 20 (1995) 137-150.